+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Defibrillators Market 2019-2025

  • ID: 4893896
  • Report
  • November 2019
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cardioline SpA
  • Defibtech, LLC
  • General Electric Co.
  • LivaNova PLC
  • MORE
Defibrillators Market Size, Share & Trends Analysis Report, By Type (Implantable Cardioverter Defibrillators and External Cardioverter Defibrillators), By End - User (Hospitals, and Ambulatory Services & Others), and Forecast 2019 - 2025.

A defibrillator is an electrical device that delivers a dose of electric current to the heart. The market is estimated to grow at a very fast pace owing to the rising prevalence of CVD and increasing investment by major players. However, the preference of drugs over defibrillators, strict FDA regulations and low awareness regarding defibrillators in the underdeveloped market are restraining the global defibrillators market. Besides these, factors such as the development of MRI labeled devices and increasing healthcare expenditure across emerging countries create ample opportunity for the growth of defibrillators industry.

The global defibrillators market is segmented on the basis of type and end - users. Based on type, the market is bifurcated into implantable cardioverter defibrillators and external cardioverter - defibrillators. Implantable cardioverter - defibrillators are expected to have a prominent share in the global market. Efficacy offered by the implantable cardioverter - defibrillators for the management of arrhythmias for a prolonged period is expected to contribute to the segmental growth of the market. Further, on the basis of end - user, the market is classified into hospitals, and ambulatory surgical centers & others. Defibrillators find a major application in hospitals due to an increasing number of patient pool with CVDs.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and RoW. North America has witnessed potential demand for defibrillators owing to the increasing prevalence of cardiovascular diseases, and supportive government policies. For instance, in 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative for preventing one million heart attacks and strokes. In addition, the presence of major players, such as Abbott Laboratories, Inc. and Boston Scientific Corp. in the region further give a boost to the regional growth of the market. Asia - Pacific region is projected to witness the fastest growth in this region. Japan is the major country in this region, contributes significantly to the defibrillators market.

Some of the key players operating in the global defibrillators market Include Medtronic PLC, Boston Scientific Corp., Koninklijke Philips N.V., Abbott Laboratories, Inc., Nihon Kohden Corp., and Asahi Kasei Corp. Partnership and collaborations, product launches and mergers and acquisitions are the key strategies adopted in the global defibrillators market. For instance, in June 2018, Philips expanded its Therapeutic Care business with the acquisition of Remote Diagnostic Technologies. RDT will complement this with a product range for the ambulance and emergency responders. This includes Tempus ALS, a modularized monitor, and defibrillator that provide premium functionality in a more flexible, lighter and smaller package. With this acquisition, the company is aimed at strengthening its capabilities and enhancing its portfolio in the major area of healthcare.

Research Methodology

The market study of the global defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country - level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro - economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research - papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for defibrillators manufacturers, medical device companies, suppliers, traders, and third - party distributors, potential investors and venture capitalists, government agencies and regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in - depth analysis on market size, products offered by the company, and future market opportunities. The report will serve as a source for 360 - degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Defibrillators Market Research and Analysis, By Type
2. Global Defibrillators Market Research and Analysis, By End - User

The Report Covers
  • Comprehensive research methodology of the global defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global defibrillators market.
  • Insights about market determinants which are stimulating the global defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cardioline SpA
  • Defibtech, LLC
  • General Electric Co.
  • LivaNova PLC
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Boston Scientific Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Koninklijke Philips N.V.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Abbott Laboratories, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Nihon Kohden Corp.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Global Defibrillators Market by End-User
5.2.1. Hospitals
5.2.2. Ambulatory Services & Others

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Bexen Cardio
7.3. Biotronik SE & Co. KG
7.4. Boston Scientific Corp.
7.5. Cardioline SpA
7.6. Cintas Corp.
7.7. Defibtech, LLC
7.8. Fukuda Denshi Co., Ltd.
7.9. General Electric Co.
7.10. HeartSine Technologies LLC
7.11. Koninklijke Philips N.V.
7.12. LivaNova PLC
7.13. Medtronic PLC
7.14. Metrax GmbH
7.15. Mindray Medical International Co. Ltd.
7.16. Nihon Kohden Corp.
7.17. Progetti srl
7.18. Schiller AG
7.19. Stryker Corp.
7.20. ZOLL Medical Corp. (an Asahi Kasei Group company)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories, Inc.
  • Bexen Cardio
  • Biotronik SE & Co. KG
  • Boston Scientific Corp.
  • Cardioline SpA
  • Cintas Corp.
  • Defibtech, LLC
  • Fukuda Denshi Co., Ltd.
  • General Electric Co.
  • HeartSine Technologies LLC
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Metrax GmbH
  • Mindray Medical International Co. Ltd.
  • Nihon Kohden Corp.
  • Progetti srl
  • Schiller AG
  • Stryker Corp.
  • ZOLL Medical Corp. (an Asahi Kasei Group company)
Note: Product cover images may vary from those shown
Adroll
adroll